Allergy

Older people adhering to the antioxidant-rich diet were less likely die from cardiovascular conditions when exposed to greater ambient air pollution.

All told, 41.5% of those receiving dupilumab every 2 weeks and 38% of those receiving it every 4 weeks achieved an Eczema Area and Severity Index score ≥75%, compared with 8% of those receiving placebo.

At the Clinical immunology Society Annual Meeting in Toronto on April 27-28, Prometic presented data from its pivotal Intravenous Immunoglobin (IVIG) Phase 3 clinical trial.

Oral immunotherapy appears to be particularly promising and has strong potential for anaphylaxis protection when administered by protocol.

After a thorough analysis of all controlled studies, no strong clinically significant evidence was observed for any individual or multicomponent intervention.

While advances have been made in understanding EoE, most studies have been descriptive and our understanding of the etiology of EoE remains elusive.